ADIPOQ and Insulin resistance: In phase III studies, ER niacin/laropiprant and ER niacin alone had similar effects on increasing plasma glucose levels [46] and the previous small study reported a similar association of increases in adiponectin and insulin resistance with ER niacin taken alone [33], and thus laropiprant may be unlikely to affect the association between changes in plasma adiponectin levels and insulin resistance.